Publications

This page lists the articles and white papers authored by the Center's faculty investigators. For additional publications from the Center, visit our Center Reports page and our blogs: Indiana Bioethics and PredictER News.

Publications 2011

Chadwick R, ten Have H, Meslin EM. Health care ethics in an era of globalisation. In Chadwick R, ten Have H, Meslin EM, Editors. The SAGE handbook of health care ethics. London: Sage Publications, 2011. p. 1-9.

Cornetta K, Meslin EM. Ethical and scientific issues in gene therapy and stem cell research. In Chadwick R, ten Have H, Meslin EM, Editors. The SAGE handbook of health care ethics. London: Sage Publications, 2011. p. 356-67.

Chen JY, Xu H, Shi P, Culbertson A, Meslin EM. Ethics and privacy considerations for systems biology applications in predictive and personalized medicine. In Liu LA, Wei D, Li Yixue, Lei H, editors. Handbook of Research on Computational and Systems Biology: Interdisciplinary Applications. Hershey, PA: IGI Global, 2011. p. 1-27.

Meslin EM. The Books Of Life And The Books In Our Lives. In Sean Caulfield, Curtis Gillespie, Timothy Caulfield, editors. Perceptions of Promise: Biotechnology, Society and Art. Edmonton, Alberta. Department of Art and Design, University of Alberta. 2011. p. 69-71.

Were MC, Meslin EM. Ethics of implementing electronic health records in developing countries: points to consider. AMIA Annu Symp Proc. 2011;2011:1499-505. PubMed PMID: 22195214

Quaid KA. Genetic counseling for frontotemporal dementias. J Mol Neurosci. 2011 Nov;45(3):706-9. PubMed PMID: 21614537.

Drabiak-Syed K. Currents in contemporary bioethics: waiving informed consent to prenatal screening and diagnosis? Problems with paradoxical negotiation in surrogacy contracts. J Law Med Ethics. 2011 Fall;39(3):559-64. PubMed PMID: 21871050

Drabiak-Syed K. Legal regulation of banking newborn blood spots for research: how Bearder and Beleno resolved the question of consent. Houston Journal of Health Law & Policy. 2011 Fall;11(1):1-45.

Meslin EM, Garba I. Biobanking and public health: is a human rights approach the tie that binds? Hum Genet. 2011 Jul 15. PubMed PMID: 21761137.

Haas DM, Gallauresi B, Shields K, Zeitlin D, Clark SM, Hebert MF, Ren Z, Nallani SC, Meslin EM, Feibus KB, Koren G, Goebel WS, Easterling T, Denne SC, Flockhart DA, Renbarger JL. Pharmacotherapy and pregnancy: highlights from the Third International Conference for Individualized Pharmacotherapy in Pregnancy. Clin Transl Sci. 2011 Jun;4(3):204-9. doi:10.1111/j.1752-8062.2011.00280.x. PubMed PMID: 21707952.

Drabiak-Syed K. Reining in the pharmacological enhancement train: we should remain vigilant about regulatory standards for prescribing controlled substances. J Law Med Ethics. 2011 Summer;39(2):272-9. PubMed PMID: 21561522

Schwartz PH. Questioning the quantitative imperative: decision aids prevention, and the ethics of disclosure. Hastings Cent Rep. 2011 Mar-Apr;41(2):30-9. PubMed PMID: 21495515

Evans JP, Meslin EM, Marteau TM, Caulfield T. Genomics. Deflating the genomic bubble. Science. 2011 Feb 18;331(6019):861-2. PubMed PMID: 21330519.

Drabiak-Syed K. Physicians prescribing "medicine" for enhancement: Why we should not and cannot overlook safety concerns. Am J Bioeth. 2011 Jan;11(1):17-9. PubMed PMID: 21240799

Publications 2010

Meslin EM, Schwartz PH. To be or not to be - a research subject? In Thomasine Kushner, editor. Surviving Health Care: A Manual for Patients and Their Families. Cambridge: Cambridge University Press, 2010.

Meslin EM. Can national bioethics commissions be progressive? Should they? In Moreno JD, Berger S, editors. Progress in bioethics: science, policy and politics. Cambridge, MA: MIT Press, 2010. p. 143.

Meslin EM. The value of using top-down and bottom-up approaches for building trust and transparency in biobanking. Public Health Genomics. 2010;13(4):207-14. Abstract: http://pubmed.gov/20395689

Meslin EM. Problem solvers: what to expect from our new bioethics commission. Science Progress. 2010 May 7. Full Text: http://www.scienceprogress.org/2010/05/problem-solvers/

Williams JK, Erwin C, Juhl AR, Mengeling M, Bombard Y, Hayden MH, Quaid KA, Shoulson I, Taylor S, Paulsen JS, and the Investigators of the Huntington Study Group. In their own words: experiences of stigma and genetic discrimination by people at-risk for Huntington disease in the international RESPOND-HD study. American Journal of Medical Genetics Part B. [in press]

Erwin C, Williams JK, Juhl A, Mengeling M, Mills Jal Bombard Y, Hayden M, Shoulson I, Taylor S, Paulsen JS, Quaid KA, and the Investigators of the Huntington Study Group. Perception, experience and response to genetic discrimination in Huntington: The international RESPOND-HD study. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2009 July;153B(5):1081-1093. Abstract: http:/pubmed.gov/20468061

Stocking CB, Hougham GW, Danner DD, Patterson MB, Whitehouse PJ, Sachs GA.  Variable judgments of decisional capacity in cognitively impaired research subjects. J Am Geriatr Soc 2008;56(10):1893-1897. [Best paper (ethics and quality of life) at Annual Meeting of American Geriatrics Society] Abstract: http://pubmed.gov/19054202

Drabiak-Syed K. Baby gender mentor: class action litigation calls attention to a deficient federal regulatory framework for DTC genetic tests, politicized state statutory construction, and a lack of informed consent. Michigan State University Journal of Medicine and Law. 2010 winter;14(1):71-92. Abstract: http://www.citeulike.org/user/cntbioet/article/8345249

Schwartz PH. 2009 Walter C. Randall Lecture in Bioethics. Autonomy and consent in biobanks. Physiologist. 2010 Feb;53(1):1,3-7. Abstract: http://pubmed.gov/20222497

Publications 2009

Meslin EM. The areas of our expertise: why we can't separate science and ethics. Science Progress. 2009 Dec 18. Available from: http://www.scienceprogress.org/2009/12/the-areas-of-our-expertise/

Kimmelman J, Weijer C, Meslin EM. The Helsinki Discords: FDA, ethics and international drug trials. The Lancet. 2009;373(9657):13-14. Abstract: http://pubmed.gov/19121708

Meslin EM. Should bioethics commissions have more authority? Bioethics Forum. 2009 Aug 4. Available from: http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=3786

Meslin EM. Bioethics as a social response to science and technology. In Sean Caulfield and Timothy Caulfield, editors. Imagining Science: Art, Science and Social Change. Edmonton: University of Alberta Press, 2009. p. 69-70.

Meslin EM. Achieving global justice in health through global research ethics: supplementing Macklin's "top-down" approach with one from the "ground-up." In Green RM, Donovan A, Jauss SA, editors. Global Bioethics: Issues of Conscience for the Twenty-first Century. New York: Oxford University Press, 2009. p. 163-77.

Sly PD, Eskenazi B, Pronczuk J, Srám R, Diaz-Barriga F, Machin DG, Carpenter DO, Surdu S, Meslin EM. Ethical issues in measuring biomarkers in children's environmental health. Environmental Health Perspectives. 2009 Aug;117(8):1185-90. Abstract: http://pubmed.gov/19672395

Drabiak-Syed K. State codification of federal regulatory ambiguities in biobanking and genetic research. The Journal of Legal Medicine. 2009;30:299-327. Abstract: http://pubmed.gov/19681010

Green RC, Roberts JS, Cupples LA, Relkin NR, Whitehouse PJ, Brown T, Eckert SL, Butson M, Sadovnick AD, Quaid KA, Chen C, Cook-Deegan R, Farrer LA; REVEAL Study Group. Disclosure of APOE genotype for risk of Alzheimer's disease. New England Journal of Medicine. 2009 Jul 16;361(3):245-54. Abstract: http://pubmed.gov/19605829

Schwartz PH. Disclosure and rationality: Comparative risk information and decision-making about prevention. Theor Med Bioeth. June 2009;30:199-213. Abstract: http://pubmed.gov/19551490

Vreeman RC, Nyandiko W, Meslin EM. Pediatric assent for a study of antiretroviral therapy dosing for children in western Kenya: a case study in international research collaboration. Journal of Empirical Research on Human Research Ethics. 2009;4(1):3-16. Abstract: http://pubmed.gov/19374483

Haas DM, Jamie L. Renbarger, JL, Denne, S,. Ahmed, MS, Easterling, T, Feibus K, Meslin EM, Koren G, Zajicek A, Snodgrass, WR, Flockhart DA. Summary of proceedings of the first international conference for individualized pharmacotherapy in pregnancy, clinical and translational science (2009);2:11-14. [Published Online: 18 Feb 2009] Available from: http://onlinelibrary.wiley.com/doi/10.1111/j.1752-8062.2009.00079.x/abstract

Quaid KA. Presymptomatic genetic testing in children. In Miller G, editor. Pediatric Bioethics. New York: Cambridge University Press, 2009. p. 125-40.

Quaid KA. Presymptomatic testing in Huntington disease. The Marker. Huntington Disease Society of America. 2009 May.

Oster E, Shoulson I, Quaid KA, and Dorsey ER. Genetic adverse selection: evidence from long term care insurance and Huntington disease. NBER Working Paper No. 15326, 2009 Sep. Abstract: http://papers.ssrn.com/sol3/papers.cfm?abstract_id=1469120

Schwartz PH. Risk and disease. Perspect Biol Med. 2008 Summer;51(3):320-34. Abstract: http://muse.jhu.edu/login?uri=/journals/perspectives_in_biology_and_medicine/v051/51.3.schwartz.html

Schwartz PH. Disclosure and rationality: comparative risk information and decision-making about prevention. Theor Med Bioeth. 2009;30(3):199-213. Abstract: http://pubmed.gov/19551490

Drabiak-Syed K. Revisiting the USPTO’s examination guidelines for gene patents: congressional inaction, USPTO restraint, and judicial remedy. Journal of International Biotechnology Law. 2009 Oct 5;6(5):204-209. Abstract: http://www.reference-global.com/doi/abs/10.1515/JIBL.2009.27

Schwartz PH. The value of information and the ethics of personal genomic screening. American Journal of Bioethics. 2009 Apr 1;9(4):26-27. Abstract: http://pubmed.gov/19326308

Schwartz PH. Autonomy and consent in biobanks.  The Physiologist. 2009 Nov. Available from: http://www.the-aps.org/publications/tphys/2010html/February/randall_lecture.htm

Publications 2008

Dure, LS, Quaid KA, Beasley, TM. A pilot assessment of parental practices and attitudes regarding risk disclosure and clinical research involving children in Huntington disease families. Genetics in Medicine. November 2008;(11):811-9; Abstract: http://pubmed.gov/18941422

Haas DM, Renbarger JL, Meslin EM, Drabiak K, Flockhart D. Patient attitudes toward genotyping in an urban women's health clinic. Obstetrics & Gynecology. November 2008; p. 1023-1028. Abstract: http://pubmed.gov/18978101

Meslin EM. Bioethics and Imagination. Spirit and Place Festival. Exploring Imagination: A Civic Collaboration of the Arts, Humanities and Religion. 2008. Available from: http://www.spiritandplace.org/spwebResources/pdf/SP%20Meslin%2041.pdf

Meslin EM. The stem cell decade: What have we learned? J of Cardiovasc Trans Res. 2008. Abstract: http://pubmed.gov/20559899

Meslin EM, Dickens, BM. Research Ethics. Singer PA, and Viens AM, eds. The Cambridge Textbook of Bioethics: Cambridge. Cambridge University Press, 2008. p. 187-193.

Meslin EM, Rooney PM, Wolf JG. Health-related philanthropy: Toward understanding the relationship between the body (and its parts) and traditional forms of philanthropic giving. Nonprofit and Voluntary Sector Quarterly. 2008;37(1):44S-62S. Abstract: http://dx.doi.org/10.1177/0899764007310531

Caulfield T, McGuire AL, Cho M, Buchanan JA, Burgess MM, Danilczyk U, Diaz CM, Fryer-Edwards K, Green SK, Hodosh MA, Juengst ET, Kaye J, Kedes L, Knoppers BM, Lemmens T, Meslin EM, Murphy J, Nussbaum RL, Otlowski M, Pullman D, Ray PN, Sugarman J, Timmons M. Research ethics recommendations for whole-genome research: consensus statement. PLOS Biology. 2008;25;6(3):e73. Abstract: http://pubmed.gov/18366258

Schwartz PH, Meslin EM. The ethics of information: Absolute risk reduction and patient understanding of screening. J Gen Intern Med. 2008.  Abstract: http://pubmed.gov/18421509

Quaid KA. Ethical and legal issues in molecular testing. In: Cheng L, Zhang DY, editors. Molecular genetic pathology. Totowa, NJ: Humana Press; 2008. p. 731-6.

Quaid KA. Genetic counseling. In: Cheng L, Zhang D, editors. Essentials of molecular genetic pathology. Totowa, NJ: Humana Press; 2008. p. 405-413.

Oster E, Dorsey ER, Bausch J, Shinaman A, Kayson E, Oakes D, Shoulson I, Quaid K; Huntington Study Group PHAROS Investigators. Fear of health insurance loss among individuals at risk for Huntington disease. Am J Med Genet A. 2008 Aug 15;146A(16):2070-7. Abstract: http://pubmed.gov/18627059

Quaid KA, Sims SL, Swenson MM, Harrison JM, Moskowitz C, Stepanov N, Suter GW, Westphal BJ. Living at risk: concealing risk and preserving hope in Huntington disease. J Genet Couns. 2008 Feb;17(1):117-28. http://pubmed.gov/17943424

Meslin EM, Johnson S. Codes, Declarations, and other ethical guidance for research with humans. National Bioethics Commissions and Research Ethics. In: The Oxford Textbook of Clinical Research Ethics. New York, NY: Oxford University Press, 2008. p. 187-197. Abstract: http://www.citeulike.org/user/cntbioet/article/2802266

Schwartz PH. Risk and disease. Perspect Biol Med. 2008 Summer;51(3):320-34. Abstract: http://pubmed.gov/18723938

Girod J, Drabiak K. A proposal for comprehensive biobank research laws to promote [translational] medicine in Indiana. Indiana Health Law Review. 2008 Jan 1;5(2). Available from: http://hdl.handle.net/1805/1843

Dure LS, Quaid K, Beasley TM. A pilot assessment of parental practices and attitudes regarding risk disclosure and clinical research involving children in Huntington disease families. Genet Med. 2008 Nov;10(11):811-9. Abstract: http://pubmed.gov/18941422

Meslin EM, Dickens BM, Research ethics. In Singer PA, Viens AM, editors. The Cambridge Textbook of Bioethics. Cambridge: Cambridge University Press, 2008. p. 187-193.

Publications 2007

Schwartz PH, Meslin EM. New technique is a promising pathway to cures. Indianapolis Star. 2007 December.

Schwartz PH. Silence about screening. [Open Peer Commentary]. Am J Bioeth. 2007 Jul;7(7):46-8. Abstract: http://pubmed.gov/17654387

Schwartz PH. Decision and discovery in defining disease. In Kincaid H, McKitrick J, editors. Establishing Medical Reality: Essays in the Metaphysics and Epistemology of Biomedical Sciences. Dordrecht: Springer, 2007. p. 47-64. Preprint available from: http://hdl.handle.net/1805/1944

Meslin EM. Ethical implications of science's plans for our well-being. Indianapolis Star. 2007 Apr.  

Caulfield T, Brown R, Meslin EM. Challenging a well established consent norm?: One time consent for biobank research. JIBL. 2007;4(1):69-74. Abstract: http://dx.doi.org/10.1515/JIBL.2007.010

Stanley FJ, Meslin EM. Australia needs a better system for health care evaluation. Med J Aust. 2007;186(5):220-21. Abstract: http://pubmed.gov/17391080

Schwartz PH. Defining dysfunction: natural selection, design, and drawing a line. Philosophy of Science. 2007;74:364-385. Abstract: http://dx.doi.org/10.1086/521970

Schwartz PH. Stem cells: biopsy on frozen embryos. Hastings Center Report. 2007;37(1):7-8. Abstract: http://www.citeulike.org/user/cntbioet/article/2802321

Evans BJ. Distinguishing product and practice regulation in personalized medicine. Clin Pharmacol Ther. 2007; 81(2):288-93. Abstract: http://pubmed.gov/17259953

Helft PR, Champion VL, Eckles R, Johnson CS, Meslin EM. Cancer patients' attitudes toward future research uses of stored human biological materials. Journal of Empirical Research in Human Research Ethics. 2007 Sept 1;2(3):15-22. Abstract: http://pubmed.gov/19385847

Publications 2006

Evans BJ, Meslin EM. Encouraging translational research through harmonization of FDA and common rule informed consent requirements for research with banked specimens. J Leg Med. 2006;27(2):119-66. Abstract: http://pubmed.gov/16728351

Sidle JE, Were E, Meslin EM, et al. A needs assessment to build international research ethics capacity. Journal of Empirical Research on Human Research Ethics. 2006;1(2):23-38. Abstract: http://pubmed.gov/19385876

Meslin EM. Shifting paradigms in health services research ethics: Consent, privacy, and the challenges for IRBs. J Gen Intern Med. 2006;21(3):279-80. Abstract: http://pubmed.gov/16637827

Meslin EM, Salmon KR, Eberl J. Eligibility for organ transplantation to foreign nationals: the relationship between citizenship, justice, and philanthropy as policy criteria. In: Keith Wailoo, Julie Livingston, Peter Guarnaccia, editors. A Death Retold: Jessica Santillan, the Bungled Transplant, and the Paradoxes of Medical Citizenship. Chapel Hill: Univ. of North Carolina Press, 2006.

Eckles RE, Meslin EM, Gaffney M, Helft P. Medical ethics education: where are we? Where should we be going? A review. Academic Medicine. 2006;80(12). Abstract: http://pubmed.gov/16306292

Shaffer DN, Yebei VN, Ballidawa JB, Meslin EM, et al. Equitable treatment for HIV/AIDS clinical trial participants: A focus group study of patients, clinician researchers, and administrators in Western Kenya. J Med Ethics. 2006;32:55-60. Abstract: http://pubmed.gov/16373525

Publications 2003 - 2005

Lavery JV, McDonald M, Meslin EM. Research ethics across the 49th parallel: the potential value of pilot testing "equivalent protections" in Canadian research institutions. Health Law Rev. 2005;13(2-3):86-96. Abstract: http://pubmed.gov/16459420

Meslin EM, Quaid KA. Ethical issues in the collection, storage, and research use of human biological materials. J Lab Clin Med. 2004;144:229-34. Abstract: http://pubmed.gov/15570240

Evans BJ, Flockhart DA, Meslin EM. Creating incentives for genomic research to improve targeting of therapies. Nature Medicine. 2004;10(12). Abstract: http://pubmed.gov/15580246

Fife R, Keener P, Meslin EM, et al. Faculty ownership of medical facilities: inappropriate conflict or an opportunity that benefits physicians and patients? Academic Medicine. 2004;79(11). Abstract: http://pubmed.gov/15504770

Caulfield T, Knowles L, Meslin EM. Law and policy in the era of reproductive genetics. J Med Ethics. 2004;30(4):14-7. Abstract: http://pubmed.gov/15289541

Quaid KA, Jessup NM, Meslin EM. Disclosure of genetic information obtained through research. Genetic Testing. 2004;8(3). Abstract: http://pubmed.gov/15727261

Meslin EM. Bioterrorism and bioethics: challenges for industry, government and society. J of Commercial Biotechnology. 2003 Jan;9(2):101-109. Abstract: http://dx.doi.org/10.1057/palgrave.jcb.3040015

Meslin EM, Martin SE. From stem to stern: A brief review of ethical issues in the stem cell debate. NeoReviews. 2003;4(7):187-93. Abstract: http://dx.doi.org/10.1542/neo.4-7-e187